Free Trial

Turnstone Biologics (TSBX) Insider Trading & Ownership

Turnstone Biologics logo
$0.36 0.00 (0.00%)
As of 08/11/2025

Turnstone Biologics (NASDAQ:TSBX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
32.10%
Number Of
Insiders Buying
(Last 3 Years)
2
Amount Of
Insider Buying
(Last 3 Years)
$7.70M
Number Of
Insiders Selling
(Last 3 Years)
0
Get TSBX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Turnstone Biologics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TSBX Insider Buying and Selling by Quarter

Turnstone Biologics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/25/2023Versant Ventures V, LlcMajor ShareholderBuy225,000$12.00$2,700,000.00  
7/20/2023Rishi GuptaDirectorBuy416,666$12.00$4,999,992.00  
(Data available from 1/1/2013 forward)

TSBX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Turnstone Biologics includes Rishi Gupta, and Versant Ventures V, Llc. Learn more on insiders at TSBX.

32.10% of Turnstone Biologics stock is owned by insiders. Learn more on TSBX's insider holdings.

Turnstone Biologics Key Executives

  • Dr. Sammy J. Farah M.B.A. (Age 51)
    Ph.D., President, CEO & Director
    Compensation: $820.88k
  • Dr. Venkat Ramanan Ph.D. (Age 54)
    Chief Financial Officer
    Compensation: $613.14k
  • Dr. Vijay Chiruvolu M.B.A. (Age 62)
    Ph.D., Interim Chief Technology Officer
    Compensation: $548.43k
  • Dr. Michael F. Burgess M.D. (Age 60)
    MBChB, Ph.D., Interim Chief Medical Officer & Executive Director
  • Dr. Stewart Abbot Ph.D. (Age 57)
    Chief Scientific Officer
  • Ms. Saryah Azmat (Age 34)
    Chief Business Officer
    Compensation: $479.73k


This page (NASDAQ:TSBX) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners